1.39k followers • 11 symbols Watchlist by Yahoo Finance
This basket consists of stocks that benefit from the needs of aging baby boomers.
Michael Avenatti is going on the offensive after federal prosecutors charged him with conspiring to extort Nike Inc.
Procter & Gamble (PG) closed the most recent trading day at $103.02, moving +1.04% from the previous trading session.
What’s Ahead for KMB and CL Stock?(Continued from Prior Part)Ratings and target prices Most analysts recommend “hold” for Kimberly-Clark (KMB) and Colgate-Palmolive (CL) stock. Both companies’ top and bottom lines are expected to fall in
Government medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate restrictions on breast implants after a day reviewing the latest research on the risks of the devices, which have been subject to safety concerns for decades. The FDA has been grappling with how to manage emerging science that shows the implants can trigger a rare form of lymphoma that grows in the scar tissue surrounding the breasts.
Allergan agreed to split its chairman and chief executive roles, but only at its next leadership change. A source close to Allergan told Reuters on Friday that current Chairman and CEO Brent Saunders, 49, has no plans to step down. Appaloosa, led by billionaire David Tepper, has been pressing Allergan since last year to separate the roles of CEO and chairman.
What’s Ahead for KMB and CL Stock?(Continued from Prior Part)Challenges continue to hurt sales and earningsKimberly-Clark (KMB) has beaten analysts’ sales estimates in the past two quarters, thanks to higher net prices. However, its sales have
What’s Ahead for KMB and CL Stock?Stock performance Kimberly-Clark (KMB) and Colgate-Palmolive (CL) have been strong this year, driven by improved organic sales due to higher pricing. However, near-term sales and earnings weakness could weigh on
Allergan stock was trading down as shareholders digested its 2019 proxy statement, in which the company butted heads with activist investor Appaloosa.
Coty (COTY) is largely benefitting from strength of its Luxury segment that accounted for about 40% of the top line in Q2. However, supply-chain hurdles continue to mar Consumer Beauty unit.
Top US Companies Impacted by Slowing European EconomyUS stock marketEarly on March 22, US stock indexes were trading on a negative note. On March 21, the stock indexes ended on a bullish note. On March 21, the S&P 500 Index, the NASDAQ
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Valuation a concernThe majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook despite better growth prospects among peers.
Positive development on the trade war front and the Fed???s dovish monetary stance are likely to be long-term catalysts for the blue-chip index.
Share are up 15% year to date, helped by the FDA’s acceptance of new applications for Botox. Still, questions remain about the health of the drugmaker’s pipeline and earnings profile.
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Top line to sustain momentum Clorox (CLX) could continue to report healthy sales growth despite pressure on net sales from currency volatility. Management expects its top
Conatus (CNAT) concentrates on the development of its lead candidate, emricasan, for treating patients with fibrosis or cirrhosis caused by NASH.
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.